The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in non–anthracycline/cyclophosphamide (AC)-based moderately emetogenic therapy (MEC).
 
Daniel Powers
Employment - TESARO
Stock and Other Ownership Interests - TESARO
Travel, Accommodations, Expenses - TESARO
 
Paul Joseph Hesketh
No Relationships to Disclose
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Genentech; Teva
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Eisai
 
Manuel R. Modiano
Stock and Other Ownership Interests - Pharmacyclics; Reliant Heart; SynCardia
 
Sujata Arora
Stock and Other Ownership Interests - TESARO
Consulting or Advisory Role - TESARO
Travel, Accommodations, Expenses - TESARO
 
Ian D. Schnadig
Employment - Compass Oncology; McKesson
Travel, Accommodations, Expenses - TESARO